Latest Security News

WA Kaolin Limited reported a $5.06 million half-year loss despite a 257% revenue surge, grappling with operational setbacks and regulatory challenges. The company’s recent debt restructuring and trading suspension signal a critical juncture as it seeks to stabilise and recapitalise.

National Storage REIT has dispatched the crucial Scheme Booklet to securityholders detailing the all-cash acquisition offer by a Brookfield and GIC consortium, setting the stage for the upcoming vote on 15 April 2026.

Helix Resources has formalised a joint venture to earn up to 40% of the Gold Basin oxide gold project in Arizona, marking a significant expansion into a prolific US gold district. The agreement sets clear milestones for exploration and resource updates over the next two years.

Novo Resources Corp has disclosed the distribution schedule and top 20 holders for its recently issued free-attaching options as part of its Tranche 1 placement, shedding light on shareholder concentration and potential capital impact.

Ausmon Resources has released amended drilling results from its Beelitz Prospect in South Australia, highlighting encouraging preliminary rare earth element concentrations and outlining plans for further exploration.

360 Capital Mortgage REIT has announced an on-market buy-back program for up to 544,337 ordinary units, set to run from March 2026 through March 2027. This move signals a strategic capital management initiative without requiring security holder approval.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Klevo Rewards’ subsidiary Fly Wallet has secured approval to join the SWIFT network, marking a key step in expanding its digital payments and rewards platform across the Asia-Pacific region.

Kina Securities Limited has launched its inaugural unsecured subordinated bond issue worth PGK 235 million, offering a fixed 7.55% coupon over 10 years, marking a significant step in Papua New Guinea's capital markets.

Arovella Therapeutics has secured TGA confirmation to advance its Phase 1 trial of ALA-101 in Australia via the efficient Clinical Trial Notification pathway, following FDA clearance in the US.

Classic Minerals has engaged AFDC to conduct a strategic review and is raising A$3 million to advance exploration at its Forrestania gold project and support its ASX relisting efforts.

Percheron Therapeutics has announced a $2.2 million non-renounceable entitlement offer at a 20% discount, including free options, to fund the next phase of its lead oncology asset HMBD-002.